This webinar will update on relapsed refractory CLL treatments today and what is on the horizon: how is a therapy chosen, how is prognosis determined and what level of involvement should patients expect in their care decisions.
The webinar seeks to explain the different types of intensive and non-intensive treatments, who can have a particular therapy, how they work, their efficacy and impact on daily living
We will be joined by:
Dr Tahla Munir Consultant in Clinical Haematology at Leeds Teaching Hospitals NHS Trust. DR Munir’s main clinical and research special interests are in chronic lymphocytic leukaemia, particularly in the assessment of the mechanism of action of novel targeted therapies.
Lianne Palmer CLL specific CNS at Oxford University Hospitals, Lianne Palmer is one of just a handful of CLL specific clinical nurse specialists across the UK.
Robin Edwards CLL patient perspective
Nick York CLL patient perspective